Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non-apolipoprotein B-containing lipoproteins in obese women

Metabolism: Clinical and Experimental

Volumn 52, Issue 12, 2003, Pages 1537-1541

  Ferrer, F ^a,b   Nazih, H ^a,b   Zair Y ^a,b   Krempf, M ^a,b   Bard, J M ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CARBOHYDRATE; CHOLESTEROL; DRINKING WATER; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; ENZYME IMMUNOASSAY; FEMALE; HIP; HUMAN; HYPERLIPIDEMIA; INGESTION; INSULIN RESISTANCE; LIPID DIET; MEAL; MULTIVARIATE ANALYSIS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 0345737204     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.004     Document Type: Article

References (40)

1. Weinberg RB, Scanu AM: Isolation and characterization of human apolipoprotein AIV from lipoprotein-depleted serum. J Lipid Res 24:52-59, 1983
2. Green PHR, Glickman RM, Riley JW, et al: Human apolipoprotein AIV. J Clin Invest 65:911-919, 1980
3. Green PHR, Glickman RM, Saudek CD, et al: Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest 64:233-242, 1979
4. Fujimoto K, Cardelli JA, Tso P: Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 262:G1002-G1006, 1992
5. Tso P, Liu M, Kalogeris TJ: The role of apolipoprotein A-IV in food intake regulation. J Nutr 129:1503-1506, 1999
6. Savion N, Gamliel A: Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells. Arteriosclerosis 8:178-186, 1988
7. Dvorin E, Gorder NL, Benson DM, et al: Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem 261:15714-15718, 1986
8. Weinberg RB, Patton CS: Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1044:255-261, 1990
9. Steinmetz A, Barbaras R, Ghalim N, et al: Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265:7859-7863, 1990
10. Von Eckardstein A, Huang Y, Wu S, et al: Lipoproteins containing apolipoprotein AIV but not apolipoprotein AI take up and esterify cell-derived cholesterol in plasma. Arterioscler Thromb Vasc Biol 15:1755-1763, 1995
11. Steinmetz A, Utermann G: Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260:2258-2264, 1985
12. Chen CH, Albers JJ: Activation of lecithin: Cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta 836:279-285, 1985
13. Emmanuel F, Steinmetz A, Rosseneu M, et al.: Identification of specific amphipathic a-helical sequence of human apolipoprotein AIV involved in lecithin: Cholesterol acyltransferase activation. J Biol Chem 269:29883-29890, 1994
14. Guyard-Dangremont V, Lagrost L, Gambert P: Comparative effects of purified apolipoproteins A-I, A-II and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 35:982-992, 1994
15. Main LA, Ohnishi T, Yokoyama S: Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein AIV. Biochim Biophys Acta 1300:17-24, 1996
16. Goldberg IJ, Scheraldi CA, Yacoub LK, et al.: Lipoprotein apoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265:4266-4272, 1990
17. Ghiselli G, Krishnan S, Beigel Y, et al.: Plasma metabolism of apolipoprotein A-IV in humans. J Lipid Res 27:813-827, 1986
18. Lagrost L, Gambert P, Boquillon M, et al.: Evidence for high density lipoproteins as the major apolipoprotein AIV-containing fraction in normal human serum. J Lipid Res 30:1525-1534, 1989
19. Lagrost L, Gambert P, Meunier S, et al.: Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J Lipid Res 30:701-710, 1989
20. Ohta T, Fidge NH, Nestel PJ: Studies on the in vivo distribution of apolipoprotein AIV in human plasma and lymph. J Clin Invest 76:1252-1260, 1985
21. Duverger N, Ghalim N, Ailhaud G, et al: Characterization of apo AIV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb Vasc Biol 13:126-132, 1993
22. Duverger N, Ghalim N, Theret N, et al: Lipoproteins containing apolipoprotein A-IV: Composition and relation to cholesterol esterification. Biochim Biophys Acta 1211:23-28, 1994
23. Malmendier CL, Lontie J-F, Lagrost L, et al: In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects. J Lipid Res 32:801-808, 1991
24. Ferrer F, Bigot-Corbel E, N'Guyen P, et al: Quantitative measurement of lipoprotein particles containing both apolipoprotein B in human plasma by a noncompetitive ELISA. Clin Chem 48:884-890, 2002
25. Vergès B, Vaillant G, Goux A, et al: Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Diabetes Care 17:810-817, 1994
26. Vergès B, Rader D, Schaefer J, et al: In vivo metabolism of apolipoprotein AIV in severe hypertriglyceridemia: A combined radiotracer and a stable isotope kinetic study. J Lipid Res 35:2280-2291, 1994
27. Bisgaier CL, Sachdev OP, Megna L, et al: Distribution of apolipoprotein A-IV in human plasma. J Lipid Res 26:11-25, 1985
28. Dallongeville J, Lebel P, Parra H-J, et al: Postprandial lipaemia is associated with increased levels of apolipoprotein AIV in the triacylglycerol-rich fraction and decreased levels in the denser plasma fractions. Br J Nutr 77:213-223, 1997
29. Sun Z, Lichtenstein AH, Dolnikowski GG, et al: Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma. Atherosclerosis 156:363-372, 2001
30. Weinberg RB, Dantzker C, Patton CS: Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 98:17-24, 1990
31. Kalogeris TJ, Painter RG: Adaptation of intestinal production of apolipoprotein AIV during chronic feeding of lipid. Am J Physiol 280:R1155-R1161, 2001
32. Verges B, Guerci B, Durlach V, et al: Increased plasma go A-IV level is a marker of abnormal postprandial lipemia. A study in normoponderal and obese subjects. J Lipid Res 42:2021-2029, 2001
33. Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60:473-485, 1979
34. Lewis GF, O'Meara NM, Soltys PA, et al: Postprandial lipoprotein metabolism in normal and obese subjects: Comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 71:1041-1050, 1990
35. Guerci B, Verges B, Durlach V, et al: Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 24:468-478, 2000
36. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
37. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostatic model assessment. Diabetologia 28:412-419, 1985
38. Matthews JN, Altman DG, Campbell MJ, et al: Analysis of serial measurements in medical research. BMJ 300:230-235, 1990
39. Vergè S, Lagrost L, Vaillant G, et al: Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. Diabetes 46:125-132, 1997
40. Seishima M, Noma A, Torizawa H, et al: Changes in serum apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis 73:39-43, 1988